Gianfranco Ferraccioli (G Ferraccioli, G F Ferraccioli)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 22

Top Topics

Combination Therapy

Disease Activity

Rheumatoid Arthritis

Top Venues

Annals of the rheumatic diseases

European journal of clinical investigation

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Josef S Smolen, Robert B M Landewe, Désirée Mfm van der Heijde, Alexandre Sepriano, Oliver M FitzGerald, Mikkel Østergaard, Joanne Homik, Ori Elkayam, J Carter Throne, Margaret J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard G Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G Cantagrel, Cornelia F Allaart, Cheryl C M Barnabe, Clifton O Bingham, Dirkjan van Schaardenburg, Hilde Berner Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P Maksymowych
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM. Rheumatology (Oxford, England) (2023)
Elisa Gremese, Barbara Tolusso, Dario Bruno, Anna Maria Paglionico, Simone Perniola, Gianfranco Ferraccioli, Stefano Alivernini
COVID-19 illness: Different comorbidities may require different immunological therapeutic targets. European journal of clinical investigation (2023)
Gianfranco Ferraccioli, Romeo Zanardi, Elisa Gremese
Case report: crowned dens syndrome in a patient with seronegative rheumatoid arthritis. RMD open 9 (2) (2023)
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, Stefania Canè, Vincenzo Bronte
Immune-Guided Therapy of COVID-19. Cancer immunology research 10 (4) (2022)
Elisa Gremese, Antonio Gasbarrini, Gianfranco Ferraccioli
HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs? RMD open 6 (1) (2021)
Elisa Gremese, Gianfranco Ferraccioli
Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks et al. Annals of the rheumatic diseases (2021)
E Gremese, Gianfranco Ferraccioli
The pathogenesis of microthrombi in COVID-19 cannot be controlled by DOAC: NETosis should be the target. Journal of internal medicine 289 (3) (2021)
György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C van der Goes, Alison Kent, Margot Bakkers, Polina Pchelnikova, Etienne Blaas, Ladislav Senolt, Zoltán Szekanecz, Ernest H S Choy, Maxime Dougados, Johannes W G Jacobs, Rinie Geenen, Johannes W J Bijlsma, Angela Zink, Daniel Aletaha, Leonard Schoneveld, Piet van Riel, Sophie Dumas, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Larissa Valor-Méndez, Kimmie L Hyrich, Ulf Mueller-Ladner, Raluca Bianca Dumitru, Iain B McInnes, Désirée Mfm van der Heijde, Jacob M van Laar
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Annals of the rheumatic diseases (2021)
Elisa Gremese, Stefano Alivernini, Gianfranco Ferraccioli
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 118 (20) (2021)
Elisa Gremese, Edoardo Sean Ferraccioli, Stefano Alivernini, Barbara Tolusso, Gianfranco Ferraccioli
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases. European journal of clinical investigation 50 (9) (2020)
Elisa Gremese, Giovanni Brondani, Luca Apollonio, Gianfranco Ferraccioli
Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'. Annals of the rheumatic diseases (2020)
György Nagy, Nadia M T Roodenrijs, Paco Mj Welsing, Melinda Kedves, Attila Hamar, Marlies C van der Goes, Alison Kent, Margot Bakkers, Etienne Blaas, Ladislav Senolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W G Jacobs, Rinie Geenen, Hans Wj Bijlsma, Angela Zink, Daniel Aletaha, Leonard Schoneveld, Piet van Riel, Loriane Gutermann, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Larissa Valor-Méndez, Kimme L Hyrich, Ulf Mueller-Ladner, Maya H Buch, Iain B McInnes, Désirée Mfm van der Heijde, Jacob M van Laar
EULAR definition of difficult-to-treat rheumatoid arthritis. Annals of the rheumatic diseases 80 (1) (2020)
Gian Luca Erre, Edoardo Sean Ferraccioli, Matteo Piga, Arduino Mangoni, Giuseppe Passiu, Elisa Gremese, Gianfranco Ferraccioli
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation? Annals of the rheumatic diseases (2020)
Gianfranco Ferraccioli
More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia. Annals of the rheumatic diseases (2020)
Stefano Alivernini, Lucy MacDonald, Aziza Elmesmari, Samuel Finlay, Barbara Tolusso, Maria Rita Gigante, Luca Petricca, Clara Di Mario, Laura Bui, Simone Perniola, Moustafa Attar, Marco Gessi, Anna Laura Fedele, Sabarinadh Chilaka, Domenico Somma, Stephen N Sansom, Andrew Filer, Charles McSharry, Neal L Millar, Kristina Kirschner, Alessandra Nerviani, Myles J Lewis, Costantino Pitzalis, Andrew R Clark, Gianfranco Ferraccioli, Irina A Udalova, Christopher Dominic Buckley, Elisa Gremese, Iain B McInnes, Thomas Dan Otto, Mariola Kurowska-Stolarska
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nature medicine 26 (8) (2020)
Edoardo Sean Ferraccioli, Elisa Gremese, Gianfranco Ferraccioli
Morbidity and Mortality From COVID-19 Are Not Increased Among Children or Patients With Autoimmune Rheumatic Disease-Possible Immunologic Rationale: Comment on the Article by Henderson et al. Arthritis & rheumatology (Hoboken, N.J.) 72 (10) (2020)
Iain B McInnes, Gianfranco Ferraccioli, Maria Antonietta D'Agostino, Manuela Le Bars, Subhashis Banerjee, Harris A Ahmad, Yedid Elbez, Phillip J Mease
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial. RMD open 5 (1) (2019)
Elisa Gremese, Stefano Alivernini, Barbara Tolusso, Martin P Zeidler, Gianfranco Ferraccioli
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. Journal of leukocyte biology 106 (5) (2019)
Roberto Felice Caporali, A Doria, Gianfranco Ferraccioli, P L Meroni, D Zavaglia, F Iannone
Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus. BioMed research international 2018 (2018)
Gian Luca Erre, Matteo Piga, Anna Laura Fedele, Silvia Mura, Alessandra Piras, Maria Luisa Cadoni, Ignazio Cangemi, Martina Dessi, Gabriele Di Sante, Barbara Tolusso, Elisa Gremese, Alberto Cauli, Arduino Aleksander Mangoni, Pier Sergio Saba, Ciriaco Carru, Gianfranco Ferraccioli, Alessandro Mathieu, Giuseppe Passiu
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study. Mediators of inflammation 2018 (2018)
Federico Biscetti, Andrea Flex, Stefano Alivernini, Barbara Tolusso, Elisa Gremese, Gianfranco Ferraccioli
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis. Mediators of inflammation 2017 (2017)
Gianfranco Ferraccioli, E Gremese
B cell activating factor (BAFF) and BAFF receptors: fakes and facts. Clinical and experimental immunology 190 (3) (2017)